Summary:
Researchers have uncovered the biological bridge connecting psychological stress to rheumatoid arthritis flares during remission. Stress activates the sympathetic nervous system to stimulate brown fat, releasing the inflammatory cytokine IL-6 into circulation; this in turn signals joint synoviocytes to recruit destructive neutrophils, reigniting localized inflammation without relying on classical autoimmune lymphocytes.
Key Facts:
- The Neuro-Adipose Trigger: Psychological restraint stress stimulates the sympathetic nervous system via β3-adrenergic receptors on brown adipose tissue (BAT), prompting the rapid systemic release of interleukin-6 (IL-6).
- The Joint Cascade: Circulating IL-6 acts on fibroblast-like synoviocytes within previously affected joints, triggering the localized secretion of chemokine CXCL1, which recruits inflammatory neutrophils to cause painful swelling.
- Targeting Without Broad Immunosuppression: Pharmacologically blocking β3-adrenergic receptors or the neutrophil chemokine receptor CXCR2 prevented stress-induced joint flares in mice, mirroring clinical findings in humans carrying a stress-blunting ADRB3 gene variant.
Source: Chiba University
Patients living with rheumatoid arthritis (RA) have long reported that emotional and psychological stress can reignite joint pain and swelling, even after their disease has entered stable clinical remission. Despite this well-known clinical correlation, the physical pathway linking mental distress in the brain to acute flare-ups in peripheral joints has remained a longstanding biological mystery.
Now, a collaborative study led by researchers from Chiba University, Asahi General Hospital, and International University of Health and Welfare Narita Hospital has mapped the entire circuit.
Publishing October 16, 2026, in Science Advances, the team demonstrated that psychological stress reactivates dormant joint inflammation through a neuro-metabolic relay involving the sympathetic nervous system and brown adipose tissue, bypassing traditional autoimmune lymphocyte pathways entirely.
Tracking the Stress Cascade from Brain to Brown Fat
To investigate how stress awakens quiescent disease, the researchers established a mouse model of rheumatoid arthritis that was allowed to subside into a remission-like state before the animals were subjected to psychological restraint stress.
Following stress exposure, the mice exhibited a rapid return of severe joint inflammation. Through detailed immune profiling, tissue analysis, and molecular tracing, the investigators mapped the chain reaction:
- Sympathetic Outflow: Psychological stress activates the sympathetic nervous system, discharging stress hormones that bind to β3-adrenergic receptors on brown adipose tissue (BAT)—metabolically active fat typically involved in non-shivering thermogenesis.
- Adipose Cytokine Surge: Instead of merely burning calories, activated brown fat responds to this sympathetic stimulation by dumping high levels of interleukin-6 (IL-6), a potent pro-inflammatory cytokine, directly into the bloodstream.
- Synovial Amplification: Once in the circulation, IL-6 travels to previously inflamed joints, where it binds to fibroblast-like synoviocytes, specialized structural cells lining the synovial membrane.
- Neutrophil Recruitment: Stimulated synoviocytes rapidly secrete the chemokine CXCL1, creating a chemical beacon that recruits swarms of inflammatory neutrophils into the joint capsule, driving acute swelling, tissue damage, and clinical flare-ups.
“Our findings suggest that the effects of psychological stress on arthritis extend beyond the immune cells traditionally associated with autoimmune disease,” said lead author Shigeru Tanaka, MD, PhD, Assistant Professor in the Department of Allergy and Clinical Immunology at Chiba University. “Instead, stress can activate processes within other tissues that contribute to the return of joint inflammation.”
Tissue Inflammatory Memory
The study provides compelling evidence that joints previously damaged by arthritis retain an epigenetic or structural “tissue inflammatory memory.” While classical T and B lymphocytes were not required to restart the acute flare, the primed fibroblast-like synoviocytes within the joint remained hypersensitive to circulating systemic stress signals.
Crucially, the research team identified multiple intervention points to disarm this pathway:
- Adrenergic Blockade: Treating mice with a selective β3-adrenergic receptor antagonist halted the cascade at its source, lowering plasma IL-6, reducing synovial CXCL1 levels, and preventing neutrophil infiltration.
- Chemokine Inhibition: Blocking CXCR2, the receptor neutrophils use to detect CXCL1, similarly suppressed stress-induced joint swelling.
“Our findings suggest that targeting the stress-responsive pathways may offer a future therapeutic strategy that acts without broadly suppressing the immune system,” emphasized senior author Hiroshi Nakajima, MD, PhD, Professor at Chiba University’s Graduate School of Medicine.
Corroboration in Human Genetics
To determine whether this stress-adipose-joint axis operates in humans, the researchers analyzed clinical and genetic cohorts of rheumatoid arthritis patients.
They focused on Trp64Arg, a known functional polymorphism in the human ADRB3 gene that dampens cellular responsiveness to adrenergic stress hormones. Strikingly, patients harboring this genetic variant displayed a significantly weaker relationship between subjective perceived stress and clinical arthritis disease activity compared to individuals with normal receptor function.
While the human observational data cannot prove direct causality, the genetic alignment reinforces the rodent findings, confirming that adrenergic sensitivity directly modulates stress-induced autoimmune susceptibility.
By exposing a neuro-metabolic axis that operates independently of classical autoimmune white blood cells, the findings offer an innovative blueprint for preventative therapeutics: selectively shielding joints from psychological stress without leaving patients vulnerable to systemic infections.
Funding:
This work was supported by JSPS KAKENHI grant 23K07890 (Shigeru Tanaka), the Japan Science and Technology Agency (Moonshot R&D) grant JPMJMS2025 (Hiroshi Nakajima), and the Agency for Medical Research and Development (AMED)-SCARDA 223fa627003h0002 (Japan Initiative for World-leading Vaccine Research and Development Center, Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa)) (Hiroshi Nakajima).
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this psychology and empathy Research:
- Media Contact: Yuka Masshardt
- Source: Chiba University
- Image Credit: Image credited to Neuroscience News
- Original Research is Open Access: Science Advances (Oct 16, 2026). “Fibroblast-like synoviocytes exacerbate autoimmune arthritis upon psychological stress in an IL-6-dependent manner.” Authors: Jun Tamura, Shigeru Tanaka, Keishi Etori, Daisuke Hashiba, Shuhei Kameda, Atsuko Tomikawa, Ryo Kikuchi, Tatsuro Takahashi, Aiko Saku, Hirotoshi Kawashima, Junichi Nakamura, Seiji Ohtori, Shin-Ichiro Kagami, Koichi Hirose, and Hiroshi Nakajima.
- DOI: 10.1126/sciadv.aec9257
Abstract
Fibroblast-like synoviocytes exacerbate autoimmune arthritis upon psychological stress in an IL-6-dependent manner
Psychological stress affects the immune system and exacerbates autoimmune diseases such as rheumatoid arthritis (RA), but the mechanisms underlying tissue inflammation during remission remain unclear.
Here, we show that tube restraint stress exacerbates joint inflammation in a murine arthritis model during remission. This exacerbation required interleukin-6 (IL-6) produced by brown adipose tissue (BAT) following sympathetic activation. Fibroblast-like synoviocytes expressing the IL-6 receptor subunit gp130 were critical mediators, as IL-6 stimulated these cells to produce the neutrophil chemoattractant CXCL1.
Pharmacological blockade of the β3-adrenergic receptor significantly attenuated stress-induced arthritis flares. In patients with RA, carriers of the hypofunctional Trp64Arg variant of ADRB3 showed no positive correlation between psychological stress and disease activity, whereas noncarriers did.
These findings identify a BAT–IL-6–fibroblast axis that reactivates inflammatory memory in arthritis and suggest that targeting stress-responsive pathways may provide a complementary therapeutic strategy alongside current RA treatments without broadly suppressing systemic immunity.
